Mature monocytic cells enter tissues and engraft

被引:83
作者
Kennedy, DW [1 ]
Abkowitz, JL [1 ]
机构
[1] Univ Washington, Div Hematol, Seattle, WA 98195 USA
关键词
D O I
10.1073/pnas.95.25.14944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The goal of this study was to identify the circulating cell that is the immediate precursor of tissue macrophages. ROSA 26 marrow mononuclear cells (containing the beta-geo transgene that encodes beta-galactosidase and neomycin resistance activities) were cultured in the presence of macrophage colony-stimulating factor and flt3 Ligand for 6 days to generate monocytic cells at all stages of maturation. Expanded monocyte cells (EMC), the immature (ER-MP12(+)) and more mature (ER-MP20(+)) subpopulations, were transplanted into irradiated B6/129 F2 mice. beta-gal staining of tissue sections from animals 15 min after transplantation demonstrated that the donor cells landed randomly. By 3 h, donor cells in lung and liver were more frequent in animals transplanted with ER-MP20(+) (more mature) EMC than in animals transplanted with unseparated EMC or fresh marrow mononuclear cells, a pattern that persisted at 3 and 7 days. At 3 days, donor cells were found in spleen, liver, lung, and brain (rarely) as clusters as well as individual cells. By 7 and 14 days, the clusters had increased in size, and the cells expressed the macrophage antigen F4/80, suggesting that further replication and differentiation had occurred. PCR for the neogene was used to quantitate the amount of donor DNA in tissues from transplanted animals and confirmed that ER-MP20(+) EMC preferentially engrafted, These data demonstrate that a mature monocytic cell gives rise to tissue macrophages. Because these cells can be expanded and manipulated in vitro, they may be a suitable target population for gene therapy of lysosomal storage diseases.
引用
收藏
页码:14944 / 14949
页数:6
相关论文
共 44 条
  • [1] F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE
    AUSTYN, JM
    GORDON, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) : 805 - 815
  • [2] METABOLIC CORRECTION AND CROSS-CORRECTION OF MUCOPOLYSACCHARIDOSIS TYPE-II (HUNTER SYNDROME) BY RETROVIRAL-MEDIATED GENE-TRANSFER AND EXPRESSION OF HUMAN IDURONATE-2-SULFATASE
    BRAUN, SE
    ARONOVICH, EL
    ANDERSON, RA
    CROTTY, PL
    MCIVOR, RS
    WHITLEY, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11830 - 11834
  • [3] BROXMEYER HE, 1995, EXP HEMATOL, V23, P1121
  • [4] Cecchini MG, 1997, MOL REPROD DEV, V46, P75
  • [5] DNAzol(R): A reagent for the rapid isolation of genomic DNA
    Chomczynski, P
    Mackey, K
    Drews, R
    Wilfinger, W
    [J]. BIOTECHNIQUES, 1997, 22 (03) : 550 - 553
  • [6] CORRELL PH, 1992, BLOOD, V80, P331
  • [7] ORIGIN, KINETICS, AND CHARACTERISTICS OF KUPFFER CELLS IN NORMAL STEADY-STATE
    CROFTON, RW
    DIESSELHOFFDENDULK, MMC
    VANFURTH, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) : 1 - 17
  • [8] High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage
    deBruijn, MFTR
    Ploemacher, RE
    Mayen, AEM
    Voerman, JSA
    Slieker, WAT
    vanEwijk, W
    Leenen, PJM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) : 2850 - 2858
  • [9] DISTINCT MOUSE BONE-MARROW MACROPHAGE PRECURSORS IDENTIFIED BY DIFFERENTIAL EXPRESSION OF ER-MP12 AND ER-MP20 ANTIGENS
    DEBRUIJN, MFTR
    SLIEKER, WAT
    VANDERLOO, JCM
    VOERMAN, JSA
    VANEWIJK, W
    LEENEN, PJM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2279 - 2284
  • [10] Freeman B., 1997, Blood, V90, p120A